BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim SH, Choi D, Kim SH, Lim JH, Lee WJ, Kim MJ, Lim HK, Lee SJ. Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol. 2005;184:1069-1076. [PMID: 15788575 DOI: 10.2214/ajr.184.4.01841069] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Murakami T, Tsurusaki M, Hyodo T, Imai Y. Clinical utility of imaging for evaluation of hepatocellular carcinoma. J Hepatocell Carcinoma 2014;1:101-8. [PMID: 27508179 DOI: 10.2147/JHC.S48602] [Reference Citation Analysis]
2 Li C, Chen R, Lii J, Chen W, Shih L, Zhang T, Tu H. Magnetic Resonance Imaging Appearance of Well-differentiated Hepatocellular Carcinoma: . Journal of Computer Assisted Tomography 2006;30:597-603. [DOI: 10.1097/00004728-200607000-00008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
3 Lee HY, Lee JM, Kim SH, Shin KS, Lee JY, Han JK, Choi BI. Detection and characterization of focal hepatic lesions: comparative study of MDCT and gadobenate dimeglumine-enhanced MR imaging. Clin Imaging 2008;32:287-95. [PMID: 18603184 DOI: 10.1016/j.clinimag.2007.11.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
4 Bendik E, Noël PB, Münzel D, Fingerle AA, Henninger M, Markus C, Vlassenbroek A, Rummeny EJ, Dobritz M. Evaluation of a method for improving the detection of hepatocellular carcinoma. Eur Radiol 2014;24:250-5. [PMID: 23996016 DOI: 10.1007/s00330-013-3006-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
5 Daniele Marin, Iannaccone R, Laghi A, Catalano C, Murakami T, Hori M, Kim T, Passariello R. Focal nodular hyperplasia: Intraindividual comparison of dynamic gadobenate dimeglumine- and ferucarbotran-enhanced magnetic resonance imaging. J Magn Reson Imaging 2007;25:775-82. [DOI: 10.1002/jmri.20885] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
6 Ito T, Takada Y, Ueda M, Haga H, Maetani Y, Oike F, Ogawa K, Sakamoto S, Ogura Y, Egawa H, Tanaka K, Uemoto S. Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation. Liver Transpl. 2007;13:1637-1644. [PMID: 18044766 DOI: 10.1002/lt.21281] [Cited by in Crossref: 168] [Cited by in F6Publishing: 154] [Article Influence: 12.0] [Reference Citation Analysis]
7 Hamer OW, Schlottmann K, Sirlin CB, Feuerbach S. Technology Insight: advances in liver imaging. Nat Rev Gastroenterol Hepatol 2007;4:215-28. [DOI: 10.1038/ncpgasthep0766] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
8 Kim SH, Choi D, Lim HK, Kim MJ, Jang KM, Kim SH, Lee WJ, Lee J, Jeon YH, Lim JH. Detection of hepatic VX2 carcinomas with ferucarbotran-enhanced magnetic resonance imaging in rabbits: Comparison of nine pulse sequences. European Journal of Radiology 2006;59:413-23. [DOI: 10.1016/j.ejrad.2006.03.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
9 Lee JM, Choi BI. Hepatocellular nodules in liver cirrhosis: MR evaluation. Abdom Imaging 2011;36:282-9. [DOI: 10.1007/s00261-011-9692-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
10 Kuo YT, Chen CY, Liu GC, Wang YM. Development of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal Model. PLoS One 2016;11:e0148695. [PMID: 26886558 DOI: 10.1371/journal.pone.0148695] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
11 Wang YX. Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application. Quant Imaging Med Surg 2011;1:35-40. [PMID: 23256052 DOI: 10.3978/j.issn.2223-4292.2011.08.03] [Cited by in F6Publishing: 226] [Reference Citation Analysis]
12 Kim SH, Kim SH, Lee J, Kim MJ, Jeon YH, Park Y, Choi D, Lee WJ, Lim HK. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol. 2009;192:1675-1681. [PMID: 19457834 DOI: 10.2214/ajr.08.1262] [Cited by in Crossref: 243] [Cited by in F6Publishing: 89] [Article Influence: 18.7] [Reference Citation Analysis]
13 Nakai M, Sato M, Ikoma A, Nakata K, Sahara S, Takasaka I, Minamiguchi H, Kawai N, Sonomura T, Kishi K. Triple-phase computed tomography during arterial portography with bolus tracking for hepatic tumors. Jpn J Radiol 2010;28:149-56. [PMID: 20182850 DOI: 10.1007/s11604-009-0399-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
14 Tsurusaki M, Sofue K, Isoda H, Okada M, Kitajima K, Murakami T. Comparison of gadoxetic acid-enhanced magnetic resonance imaging and contrast-enhanced computed tomography with histopathological examinations for the identification of hepatocellular carcinoma: a multicenter phase III study. J Gastroenterol. 2016;51:71-79. [PMID: 26130441 DOI: 10.1007/s00535-015-1097-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
15 Kim SH, Lee WJ, Lim HK, Park CK. SPIO-enhanced MRI findings of well-differentiated hepatocellular carcinomas: correlation with MDCT findings. Korean J Radiol 2009;10:112-20. [PMID: 19270856 DOI: 10.3348/kjr.2009.10.2.112] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
16 Mainenti PP, Mancini M, Mainolfi C, Camera L, Maurea S, Manchia A, Tanga M, Persico F, Addeo P, D'Antonio D, Speranza A, Bucci L, Persico G, Pace L, Salvatore M. Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents. Abdom Imaging. 2010;35:511-521. [PMID: 19562412 DOI: 10.1007/s00261-009-9555-2] [Cited by in Crossref: 69] [Cited by in F6Publishing: 59] [Article Influence: 5.3] [Reference Citation Analysis]
17 Hirakawa M, Yoshimitsu K, Irie H, Tajima T, Nishie A, Asayama Y, Ishigami K, Kakihara D, Taketomi A, Aishima S, Honda H. Performance of radiological methods in diagnosing hepatocellular carcinoma preoperatively in a recipient of living related liver transplantation: comparison with step section histopathology. Jpn J Radiol 2011;29:129-37. [DOI: 10.1007/s11604-010-0528-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
18 Golfieri R, Marini E, Bazzocchi A, Fusco F, Trevisani F, Sama C, Mazzella G, Cavuto S, Piscaglia F, Bolondi L. Small (<or=3 cm) hepatocellular carcinoma in cirrhosis: the role of double contrast agents in MR imaging vs. multidetector-row CT. Radiol Med. 2009;114:1239-1266. [PMID: 19697104 DOI: 10.1007/s11547-009-0439-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
19 Lencioni R, Crocetti L, Della Pina MC, Cioni D. Guidelines for imaging focal lesions in liver cirrhosis. Expert Review of Gastroenterology & Hepatology 2014;2:697-703. [DOI: 10.1586/17474124.2.5.697] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
20 Lee JY, Kim SH, Jeon YH, Lee J, Kim MJ, Choi D, Lee WJ. Ferucarbotran-Enhanced Magnetic Resonance Imaging Versus Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for the Preoperative Detection of Hepatocellular Carcinoma: Initial Experience. Journal of Computer Assisted Tomography 2010;34:127-34. [DOI: 10.1097/rct.0b013e3181b1587a] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
21 Hassan A, Al-ajami R, Dashti K, Abdoelmoneum M. Sixty-four multi-slice computed tomography and magnetic resonance imaging in evaluation of hepatic focal lesions. The Egyptian Journal of Radiology and Nuclear Medicine 2011;42:101-10. [DOI: 10.1016/j.ejrnm.2011.01.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
22 Lee YH, Kim SH, Cho M, Shim KY, Kim MS. Focal Nodular Hyperplasia-Like Nodules in Alcoholic Liver Cirrhosis: Radiologic-Pathologic Correlation. American Journal of Roentgenology 2007;188:W459-63. [DOI: 10.2214/ajr.05.1998] [Cited by in Crossref: 24] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
23 Chen R, Lii J, Chou C, Chang T, Chen W, Li C, Tu H. T2-weighted and T1-weighted Dynamic Superparamagnetic Iron Oxide (Ferucarbotran) Enhanced MRI of Hepatocellular Carcinoma and Hyperplastic Nodules. Journal of the Formosan Medical Association 2008;107:798-805. [DOI: 10.1016/s0929-6646(08)60193-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
24 Bartolozzi C, Crocetti L, Lencioni R, Cioni D, Della Pina C, Campani D. Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media. Eur Radiol 2007;17:2519-30. [DOI: 10.1007/s00330-007-0602-5] [Cited by in Crossref: 68] [Cited by in F6Publishing: 53] [Article Influence: 4.5] [Reference Citation Analysis]
25 Vilana R, Forner A, García Á, Ayuso C, Bru C. Carcinoma hepatocelular: diagnóstico, estadificación y estrategia terapéutica. Radiología 2010;52:385-98. [DOI: 10.1016/j.rx.2010.05.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
26 Koda M, Tokunaga S, Fujise Y, Kato J, Matono T, Sugihara T, Nagahara T, Ueki M, Murawaki Y, Kakite S. Assessment of ablative margin after radiofrequency ablation for hepatocellular carcinoma; comparison between magnetic resonance imaging with ferucarbotran and enhanced CT with iodized oil deposition. Eur J Radiol. 2012;81:1400-1404. [PMID: 21440397 DOI: 10.1016/j.ejrad.2011.03.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
27 Macarini L, Milillo P, Cascavilla A, Scalzo G, Stoppino L, Vinci R, Moretti G, Ettorre G. MR characterisation of dysplastic nodules and hepatocarcinoma in the cirrhotic liver with hepatospecific superparamagnetic contrast agents: pathological correlation in explanted livers. Radiol med 2009;114:1267-82. [DOI: 10.1007/s11547-009-0464-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
28 Mikami S, Tateishi R, Akahane M, Asaoka Y, Kondo Y, Goto T, Shiina S, Yoshida H, Koike K. Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience. J Vasc Interv Radiol. 2012;23:1269-1275. [PMID: 22999746 DOI: 10.1016/j.jvir.2012.06.032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
29 Tsurusaki M, Sugimoto K, Fujii M, Fukuda T, Matsumoto S, Sugimura K. Combination of CT during arterial portography and double-phase CT hepatic arteriography with multi-detector row helical CT for evaluation of hypervascular hepatocellular carcinoma. Clinical Radiology 2007;62:1189-97. [DOI: 10.1016/j.crad.2007.05.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
30 Glockner JF. Hepatobiliary MRI: current concepts and controversies. J Magn Reson Imaging. 2007;25:681-695. [PMID: 17352396 DOI: 10.1002/jmri.20844] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
31 Choi YR, Chung JW, Yu MH, Lee M, Kim JH. Diagnostic accuracy of contrast-enhanced dynamic CT for small hypervascular hepatocellular carcinoma and assessment of dynamic enhancement patterns: Results of two-year follow-up using cone-beam CT hepatic arteriography. PLoS One. 2018;13:e0203940. [PMID: 30231076 DOI: 10.1371/journal.pone.0203940] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
32 Park JM, Kim IY, Kim SW, Lee SM, Kim HG, Kim SY, Shin HC. A comparative study of FDG PET/CT and enhanced multi-detector CT for detecting liver metastasis according to the size and location. Ann Nucl Med 2013;27:217-24. [PMID: 23242953 DOI: 10.1007/s12149-012-0677-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
33 Savranoglu P, Obuz F, Karasu S, Coker A, Secil M, Sagol O, Igci E, Dicle O, Astarcioglu I. The role of SPIO-enhanced MRI in the detection of malignant liver lesions. Clin Imaging 2006;30:377-81. [PMID: 17101405 DOI: 10.1016/j.clinimag.2006.06.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
34 Tanaka Y, Nakazawa T, Inoue T, Yamane K, Kubota K, Uojima H, Takada J, Okuwaki Y, Hidaka H, Shibuya A, Kokubu S, Matsunaga K, Koizumi W. Superparamagnetic iron oxide-enhanced magnetic resonance imaging is useful in predicting malignant potential of vascular transformation of hypointense hypovascular nodules on gadoxetic acid-enhanced magnetic resonance imaging. Hepatol Res 2017;47:1118-26. [PMID: 27943555 DOI: 10.1111/hepr.12850] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
35 Kim HS, Kim SH, Kang TW, Song KD, Choi D, Park CK. Value of gadoxetic acid-enhanced and diffusion-weighted MR imaging in evaluation of hepatocellular carcinomas with atypical enhancement pattern on contrast-enhanced multiphasic MDCT in patients with chronic liver disease. European Journal of Radiology 2015;84:555-62. [DOI: 10.1016/j.ejrad.2014.12.023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
36 Hwang J, Kim SH, Lee MW, Lee JY. Small (≤ 2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT. Br J Radiol 2012;85:e314-22. [PMID: 22167508 DOI: 10.1259/bjr/27727228] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
37 Chanyaputhipong J, Low SC, Chow PK. Gadoxetate Acid-Enhanced MR Imaging for HCC: A Review for Clinicians. Int J Hepatol. 2011;2011:489342. [PMID: 21994860 DOI: 10.4061/2011/489342] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
38 . Chapter 2: Diagnosis and surveillance: Chapter 2: Diagnosis and surveillance. Hepatology Research 2010;40:16-47. [DOI: 10.1111/j.1872-034x.2010.00655.x] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
39 Saar B, Kellner-Weldon F. Radiological diagnosis of hepatocellular carcinoma. Liver Int. 2008;28:189-199. [PMID: 18251978 DOI: 10.1111/j.1478-3231.2007.01655.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
40 Kim SJ, Kim SH, Lee J, Chang S, Kim Y, Kim SH, Jeon YH, Choi D. Ferucarbotran-Enhanced 3.0-T Magnetic Resonance Imaging Using Parallel Imaging Technique Compared With Triple-Phase Multidetector Row Computed Tomography for the Preoperative Detection of Hepatocellular Carcinoma: . Journal of Computer Assisted Tomography 2008;32:379-85. [DOI: 10.1097/rct.0b013e3180de5c80] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
41 Tanimoto A, Kuribayashi S. Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma. Eur J Radiol 2006;58:200-16. [PMID: 16414230 DOI: 10.1016/j.ejrad.2005.11.040] [Cited by in Crossref: 100] [Cited by in F6Publishing: 83] [Article Influence: 6.3] [Reference Citation Analysis]
42 van den Bos IC, Hussain SM, Terkivatan T, Zondervan PE, de Man RA. Stepwise carcinogenesis of hepatocellular carcinoma in the cirrhotic liver: demonstration on serial MR imaging. J Magn Reson Imaging. 2006;24:1071-1080. [PMID: 17024654 DOI: 10.1002/jmri.20701] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
43 Cheng WZ, Zeng MS, Yan FH, Rao SX, Shen JZ, Chen CZ, Zhang SJ, Shi WB. Ferucarbotran versus Gd-DTPA-enhanced MR imaging in the detection of focal hepatic lesions. World J Gastroenterol 2007; 13(36): 4891-4896 [PMID: 17828821 DOI: 10.3748/wjg.v13.i36.4891] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
44 Tanimoto A. Use of SPIOs for Clinical Liver Imaging. In: Bulte JW, Modo MM, editors. Nanoparticles in Biomedical Imaging. New York: Springer; 2008. pp. 41-61. [DOI: 10.1007/978-0-387-72027-2_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Wu LM, Xu JR, Gu HY, Hua J, Chen J, Zhu J, Zhang W, Hu J. Is liver-specific gadoxetic acid-enhanced magnetic resonance imaging a reliable tool for detection of hepatocellular carcinoma in patients with chronic liver disease? Dig Dis Sci. 2013;58:3313-3325. [PMID: 23884757 DOI: 10.1007/s10620-013-2790-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
46 Yukisawa S, Okugawa H, Masuya Y, Okabe S, Fukuda H, Yoshikawa M, Ebara M, Saisho H. Multidetector helical CT plus superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions in cirrhotic liver: a comparison with multi-phase CT during hepatic arteriography. Eur J Radiol 2007;61:279-89. [PMID: 17070663 DOI: 10.1016/j.ejrad.2006.09.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
47 Ayyappan AP, Jhaveri KS. CT and MRI of hepatocellular carcinoma: an update. Expert Rev Anticancer Ther. 2010;10:507-519. [PMID: 20397916 DOI: 10.1586/era.10.24] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
48 Heilmaier C, Lutz AM, Bolog N, Weishaupt D, Seifert B, Willmann JK. Focal liver lesions: detection and characterization at double-contrast liver MR Imaging with ferucarbotran and gadobutrol versus single-contrast liver MR imaging. Radiology 2009;253:724-33. [PMID: 19789232 DOI: 10.1148/radiol.2533090161] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]